Market revenue in 2023 | USD 12.9 million |
Market revenue in 2030 | USD 29.0 million |
Growth rate | 12.3% (CAGR from 2023 to 2030) |
Largest segment | Ferric carboxymaltose |
Fastest growing segment | Ferric Carboxymaltose |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Iron Dextran, Iron Sucrose, Ferric Carboxymaltose |
Key market players worldwide | AbbVie Inc, Civitas Resources Inc Ordinary Shares, Daiichi Sankyo Co Ltd, Sanofi SA, CSL Ltd, COSMOS Pharmaceutical Corp, Zydus Lifesciences, Rockwell Medical Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous iron drugs market will help companies and investors design strategic landscapes.
Ferric carboxymaltose was the largest segment with a revenue share of 49.61% in 2023. Horizon Databook has segmented the South Africa intravenous iron drugs market based on iron dextran, iron sucrose, ferric carboxymaltose covering the revenue growth of each sub-segment from 2018 to 2030.
Rising number of government initiatives intended to boost awareness among locals is expected to bolster market growth in the region. For instance, the standard treatment guidelines and essential medicines list are released by the Health Republic of South Africa.
However, the healthcare expenditure of the country is very low and most of the tests & procedures are inaccessible to the majority of the population. Based on an article published in March 2022, the prevalence of anemia in parts of Africa was 65.62% in west and in east Africa it was 54.83%.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa intravenous iron drugs market , including forecasts for subscribers. This country databook contains high-level insights into South Africa intravenous iron drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account